Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Solov'ev

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Vutreshni Bolesti|January 1, 1988
[Extracorporeal immunotherapy of rheumatic diseases]S K Solov'ev
Terapevticheskii Arkhiv|May 21, 2010
[Advances and prospects in the treatment of systemic lupus erythematosus]M M Ivanova, S K Solov'ev
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|February 13, 1999
[Synchronous intensive treatment for patients with systemic lupus erythematosus having poor life prognosis]S K Solov'ev, V A Nasonov
Terapevticheskii Arkhiv|January 1, 1980
[Ultra-high (shock) doses of methylprednisolone in lupus nephritis]S K Solov'ev, M M Ivanova
Klinicheskaia Meditsina|June 5, 1999
[Treatment of rheumatic arthritis: role of glucocorticoids]E L Nasonov, S K Solov'ev, N Iu Lashina
Klinicheskaia Meditsina|June 1, 1991
[Cryoglobulinemia in rheumatic diseases]A A Baranauskaĭte, E L Nasonov, S K Solov'ev
Terapevticheskii Arkhiv|August 28, 2001
[Extracorporeal therapy of rheumatoid arthritis]E A Aseeva, S K Solov'ev, A S Chiklikchi
Terapevticheskii Arkhiv|December 8, 2000
[Treatment with megadoses of dexaven (dexamethasone) versus methypred (6-methylprednisolone) of patients with rheumatoid arthritis]N Iu Lashina, S K Solov'ev, R M Balabanova
Terapevticheskii Arkhiv|January 1, 1980
[Dynamic studies of skin microcirculation during treatment of lupus nephritis with cytostatic immunosuppressants]E S Mach, S K Solov'ev, M M Ivanova
Terapevticheskii Arkhiv|January 1, 1986
[Characteristics of the spontaneous humoral immunity reactions to collagen type I in systemic lupus erythematosus patients]Iu V Nesvizhskiĭ, S K Solov'ev, A F Panasiuk
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Vutreshni Bolesti|January 1, 1988
[Extracorporeal immunotherapy of rheumatic diseases]S K Solov'ev
Terapevticheskii Arkhiv|May 21, 2010
[Advances and prospects in the treatment of systemic lupus erythematosus]M M Ivanova, S K Solov'ev
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk|February 13, 1999
[Synchronous intensive treatment for patients with systemic lupus erythematosus having poor life prognosis]S K Solov'ev, V A Nasonov
Terapevticheskii Arkhiv|January 1, 1980
[Ultra-high (shock) doses of methylprednisolone in lupus nephritis]S K Solov'ev, M M Ivanova
Klinicheskaia Meditsina|June 5, 1999
[Treatment of rheumatic arthritis: role of glucocorticoids]E L Nasonov, S K Solov'ev, N Iu Lashina
Klinicheskaia Meditsina|June 1, 1991
[Cryoglobulinemia in rheumatic diseases]A A Baranauskaĭte, E L Nasonov, S K Solov'ev
Terapevticheskii Arkhiv|August 28, 2001
[Extracorporeal therapy of rheumatoid arthritis]E A Aseeva, S K Solov'ev, A S Chiklikchi
Terapevticheskii Arkhiv|December 8, 2000
[Treatment with megadoses of dexaven (dexamethasone) versus methypred (6-methylprednisolone) of patients with rheumatoid arthritis]N Iu Lashina, S K Solov'ev, R M Balabanova
Terapevticheskii Arkhiv|January 1, 1980
[Dynamic studies of skin microcirculation during treatment of lupus nephritis with cytostatic immunosuppressants]E S Mach, S K Solov'ev, M M Ivanova
Terapevticheskii Arkhiv|January 1, 1986
[Characteristics of the spontaneous humoral immunity reactions to collagen type I in systemic lupus erythematosus patients]Iu V Nesvizhskiĭ, S K Solov'ev, A F Panasiuk
Pageof 5